Evaluation of an automated CRISPR-based diagnostic tool for rapid detection of COVID-19

Democratizing nucleic acid-based molecular diagnostic tests for infectious diseases at resource-limited settings – from point of care to extreme point of care

“…66 The evaluation of a cost-effective CRISPR-based automated detection method for the rapid detection of SARS-CoV2 was reported by Xu et al , elucidating its high efficacy. 67…”

“…66 The evaluation of a costeffective CRISPR-based automated detection method for the rapid detection of SARS-CoV2 was reported by Xu et al, elucidating its high efficacy. 67 Like several other NAATs, the field deployment of CRISPRbased diagnostics at resource-limited settings brings in some critical challenges that cannot be offset trivially. First, the sample processing involves lengthy protocols and often relies on instrumentation.…”